Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants
Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Cefiderocol (FDC) and ceftazidime-avibactam (CZA) are among the latest generation of commercialized antibiotics against carbapenem-resistant Gram negatives. However, emergence of CZA resistance is being increasingly reported, involving different KPC variants in
Enterobacterales
. By analyzing two CZA-resistant KPC-3 clinical variants, KPC-41...
Alternative Titles
Full title
Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2623890826
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2623890826
Other Identifiers
ISSN
0934-9723
E-ISSN
1435-4373
DOI
10.1007/s10096-021-04397-x
